• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVOCURE GMBH OPTUNE GIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVOCURE GMBH OPTUNE GIO Back to Search Results
Model Number TFH9100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fall (1848); Laceration(s) (1946)
Event Date 02/13/2024
Event Type  Injury  
Manufacturer Narrative
Novocure medical opinion is that a contribution of the device use to the fall and to the secondary reported skin laceration cannot be excluded.Fall is an expected event with optune gio device use (ef-11 4% and 8% ef-14 optune arm).Skin laceration is an expected event with optune gio device use (ef-11 0% and 1% ef-14 optune arm).
 
Event Description
An 85-year-old female with newly diagnosed glioblastoma (gbm) started optune gio therapy on (b)(6) 2022.On (b)(6) 2024, the patient reported that she fell the day prior when she wanted to cross the street, sustaining a 3 cm long occipital skin laceration on her head.The patient mentioned she fell over the device backpack.Following the fall, the patient was taken to the emergency room (er) by ambulance.In the er, the patient was not able to remember the fall.The occipital head wound was closed using medical glue.Head ct was performed and no further injuries were detected.The patient was discharged to home on the same day.The prescribing physician did confirm that the patient sustained a skin laceration, which required treatment.He did not provide a causality on the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTUNE GIO
Type of Device
OPTUNE GIO
Manufacturer (Section D)
NOVOCURE GMBH
business village d4
park 6/platz 10
root d4, 6039
SZ  6039
Manufacturer (Section G)
NOVOCURE GMBH
business village d4
park 6/platz 10
root d4, 6039
SZ   6039
Manufacturer Contact
sharon perez
195 commerce way
portsmouth, NH 03801
2077527602
MDR Report Key18902315
MDR Text Key337636177
Report Number3010457505-2024-00262
Device Sequence Number1
Product Code NZK
UDI-Device Identifier07290107981194
UDI-Public(01)07290107981194(11)200323
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 03/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberTFH9100
Device Catalogue NumberTFH9100EU
Was Device Available for Evaluation? No
Date Manufacturer Received02/14/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/23/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
ACETYLSALICYLIC ACID; ATORVASTATINE; DOXYCYCLINE; MEBENDAZOLE; METFORMIN
Patient Outcome(s) Required Intervention;
Patient Age85 YR
Patient SexFemale
-
-